1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Hyperlipoproteinemia Type IV: new trials by email Literature Review of Hyperlipoproteinemia Type IV trials Research Report on Hyperlipoproteinemia Type IV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Triglyceride Lowering Study Omega-3-Acid Ethyl Esters - Hypertriglyceridemia | Phase 4 | Unknown | Jewish Hospital, Cincinnati, Ohio | 25 | 2009-07-01 | 2009-07-08 |
| Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients rosuvastatin - Hypertriglyceridemia, Hyperlipoproteinemia Type IV | Phase 4 | Completed | AstraZeneca | 334 | 2007-01-01 | 2010-12-16 |
Hypertriglyceridemia (2) · Hyperlipidemias (1) · Hyperlipoproteinemia Type II (1) · Hyperlipoproteinemia Type V (1) · Hyperlipoproteinemias (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dyslipidemias (2) · Genetic Diseases, Inborn (2) · Lipid Metabolism Disorders (2) · Lipid Metabolism, Inborn Errors (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2) · Hyperlipidemias (1) · Hyperlipoproteinemias (1)
Omacor (1) · Rosuvastatin Calcium (1)
AstraZeneca (1) · Jewish Hospital, Cincinnati, Ohio (1)
Mexico (1) · United States (1)
Ana Polanco, MD (1) · Charles Glueck, MD (1) · Juan Talavera, MD (1)